Kirloskar Brothers Limited announced its unaudited financial results for the second quarter and half-year ended September 30, 2025. The standalone revenue from operations for...
Glenmark Pharmaceuticals has scheduled a board meeting on November 14, 2025, to consider and approve the unaudited financial results for the second quarter and...
Niva Bupa Health Insurance Company Limited's Board of Directors has approved the standalone unaudited financial results for Q2 2026, ending September 30, 2025. The...
Emcure Pharmaceuticals has announced a board meeting scheduled for November 11, 2025, to review and approve the unaudited financial results for the quarter and...